Midostaurin administration in two hemodialysis patients

Tollkuci, E; Seddon, A; Geswein, L; Mulseh, M

Tollkuci, E (reprint author), Rosalind Franklin Univ Med & Sci, 3333 Green Bay Rd, N Chicago, IL 30064 USA.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019; 25 (5): 1285

Abstract

Midostaurin is a multitargeted tyrosine kinase inhibitor approved by the Food and Drug Administration for FMS-related tyrosine kinase 3-positive acute......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索